Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.68
+0.06 (1.07%)
At close: Nov 6, 2026, 4:00 PM EST
5.58
-0.10 (-1.76%)
After-hours: Nov 6, 2026, 7:30 PM EST
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 86 employees as of December 31, 2025. The number of employees increased by 16 or 22.86% compared to the previous year. That makes Orchestra BioMed Holdings the 32,362nd largest employer in the world and 4,190th in the United States.
Employees
86
Change (1Y)
16
Growth (1Y)
22.86%
Revenue / Employee
$371,814
Profits / Employee
-$692,698
Market Cap
341.40M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 86 | 16 | 22.86% |
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | 11 | 24.44% |
| Sep 30, 2022 | 45 | - | - |
| Jun 30, 2022 | 42 | - | - |
| Mar 31, 2022 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| Lyell Immunopharma | 161 |
| MapLight Therapeutics | 133 |
| TRex Bio | 60 |
| Atea Pharmaceuticals | 55 |
| Contineum Therapeutics | 51 |
| Fennec Pharmaceuticals | 35 |
| Opus Genetics | 28 |
OBIO News
- 1 day ago - Orchestra BioMed Announces Pricing of Public Offering - GlobeNewsWire
- 1 day ago - Orchestra BioMed announces common stock offering, no amount given - TheFly
- 8 days ago - Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026 - GlobeNewsWire
- 15 days ago - Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB - GlobeNewsWire
- 5 weeks ago - Orchestra BioMed surpasses full enrollment in BACKBEAT trial - TheFly
- 5 weeks ago - Orchestra BioMed Exceeds Full Enrollment Target in the BACKBEAT Global Pivotal Trial of AVIM Therapy - GlobeNewsWire
- 5 weeks ago - OBIO's Capital Access Advisory Program (CAAP®) Reaches Milestone with $1 Billion Raised by High-Growth Life Sciences and Health Tech Ventures - Business Wire
- 7 weeks ago - Orchestra BioMed Announces AVIM Therapy to Be Featured in Two Sessions at HRX Live 2026 - GlobeNewsWire